News & Insights

The Israeli Supreme Court has rendered its important and controversial decision in the Sanofi v. Unipharm case, holding that a Patent Applicant who intentionally deceives the Patent Office in order to obtain a patent, may be liable, under the Israeli law of unjust enrichment, to pay generic competitors who delayed entering the market at risk because of this patent application, restitution of the profits gained at their expense as a result of this deception.

In a few months a monumental change in the European patent landscape will take place with the coming into force of the Unified Patent Court (UPC) of the European Union (EU). This change will permit patentees to have a single Unified Patent (UP) across most of EU territory and, hence, covering one of the three largest economic regions of the world.

The World Intellectual Property Organization (WIPO) published a report earlier this week on global intellectual property (IP) activity in 2020. There are some very interesting findings in this report, that provide an insight on global economic activity and trends, as summarized below.

The Israeli Parliament (the Knesset) has voted, in a first reading, in favor of a proposed amendment to the Israeli Patents Law (1967) that aims to increase the global competitive advantage of Israeli generic pharmaceutical companies.